Hongtao Yu

10PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesCardiology (incl. cardiovascular diseases)Computational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

|May 09, 2025
Pharmacokinetic-pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus.

Hongtao Yu, Victoria Parker, Viknesh Selvarajah

|Jul 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach.

Hongtao Yu, Sebastian Ueckert, Lina Zhou

|Jan 18, 2024
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis.

Hongtao Yu, Magnus Åstrand, Jenny Cheng

|Nov 13, 2023
Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling.

Sanchita Basu, Hongtao Yu, Jonathan R Murrow

|Oct 17, 2021
Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis.

Hongtao Yu, Sanchita Basu, Weifeng Tang

Pageof 2

Frequent Collaborators

4 joint publications

K Melissa Hallow

2 joint publications

Peter J Greasley

2 joint publications

David W Boulton

2 joint publications

Anis Khan